Lara Longpre - 10 May 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Development Officer
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 May 2023
Net transactions value
+$11,576
Form type
4
Filing time
19 May 2023, 16:05:57 UTC
Previous filing
02 Feb 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $11,576 +684 +0.64% $16.92 106,843 10 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 684 shares by the Reporting Person on May 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.